This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
ASCO GU 2022
ASCO GU 2022 Prostate Cancer
Conferences
ASCO GU 2022
Prostate Cancer
Penile, Urethral, Testicular, and Adrenal Cancers
Press Releases
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Carcinoma
ASCO GU 2022 Prostate Cancer
Viewing 81-100 of 316 articles
ASCO GU 2022: Management of Rare Variants in Genitourinary Cancers: Systemic Therapy for Rare Variants of Urothelial Cancer
ASCO GU 2022: Impact of Provider Education on Prostate Cancer Genetic Counseling Referrals
ASCO GU 2022: A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer
ASCO GU 2022: Characteristics of Prostate Cancer Survivors Exposed to ADT and Enrolled in a Fall Prevention Exercise Trial: Comparison of Men With Confirmed Fall History to Men With Fall Risk Factors
ASCO GU 2022: DS-7300 (B7-H3 DXd-ADC) in Patients With Metastatic Castration-Resistant Prostate Cancer: A Subgroup Analysis of a Phase 1/2 Multicenter Study
ASCO GU 2022: Factors Associated With Gene Mutation Testing in United States Veterans With Metastatic Castration-Resistant Prostate Cancer
ASCO GU 2022: Local Therapies for Variant Histology in Bladder Cancer
ASCO GU 2022: Discussion on the ARASENS and PRESIDE Trials
ASCO GU 2022: A Quantitative Synthesis of Disparities in the Inclusion of Racial/Ethnic Minorities and Older Adults in Prostate Cancer Clinical Trials Over the Last Three Decades
ASCO GU 2022: Tailoring 4Kscore Thresholds to Multiparametric MRI ResultsĀ
ASCO GU 2022: Financial Toxicity and Its Effect on Screening for Prostate and Colon Cancer
ASCO GU 2022: Endocrine Tumors of the Genitourinary Tract
ASCO GU 2022: Homing in on Tumor Antigens With Antibody-Drug Conjugates in Advanced Urothelial Cancer: Basic Principles
ASCO GU 2022: A Phase 3, Randomized, Open-Label, Multicenter, Global Study of the Efficacy and Safety of Durvalumab + Tremelimumab + Enfortumab Vedotin or Durvalumab + EV for Neoadjuvant Treatment in Cisplatin-Ineligible MIBC (VOLGA)
ASCO GU 2022: Adjuvant Infigratinib As Targeted Therapy for Patients With Muscle-Invasive Urothelial Carcinoma Harboring Susceptible FGFR3 Genetic Alterations: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial (PROOF 302)
ASCO GU 2022: PIVOT IO 009: A Phase 3, Randomized Study of Neoadjuvant and Adjuvant Nivolumab Plus Bempegaldesleukin Versus NIVO Alone Versus Standard of Care in Patients With MIBC Who Are Cisplatin-Ineligible
ASCO GU 2022: SunRISe-1: Phase 2b Study of TAR-200 Plus Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With High-Risk Nonmuscle-Invasive Bladder Cancer Unresponsive to BCG Who Are Ineligible for or Decline Radical Cystectomy
ASCO GU 2022: TROPiCS-04: Study of Sacituzumab Govitecan in Patients With Locally Advanced Unresectable or Metastatic Urothelial Cancer That Has Progressed After Prior Platinum and Checkpoint Inhibitor Therapy
ASCO GU 2022: Study EV-302: A Two-Arm, Open-Label, Randomized Controlled Phase 3 Study of Enfortumab Vedotin in Combination With Pembrolizumab Versus Chemotherapy in Previously Untreated Advanced Urothelial Carcinoma
ASCO GU 2022: Systemic Therapy for the Management of Rare Prostate Cancer Variants
1
2
3
4
5
6
7
8
9
10
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free